Free Trial
TSE:SVA

Sernova (SVA) Stock Price, News & Analysis

C$0.28
+0.01 (+3.70%)
(As of 07/26/2024 ET)
Today's Range
C$0.26
C$0.28
50-Day Range
C$0.27
C$0.39
52-Week Range
C$0.26
C$0.94
Volume
81,601 shs
Average Volume
154,122 shs
Market Capitalization
C$84.95 million
P/E Ratio
N/A
Dividend Yield
7.86%
Price Target
C$1.50

Sernova MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
435.7% Upside
C$1.50 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.88mentions of Sernova in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
C$30,270 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.23 out of 5 stars

SVA stock logo

About Sernova Stock (TSE:SVA)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

SVA Stock Price History

SVA Stock News Headlines

We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
Sernova Provides Organizational Update
We’re in a code red crisis and 99% of Americans are clueless
Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!
Sernova Corp (PSH.MU)
Sernova Corp SVA
H.C. Wainwright Thinks Sernova’s Stock is Going to Recover
H.C. Wainwright Reaffirms Their Buy Rating on Sernova (SVA)
See More Headlines
Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/14/2024
Today
7/26/2024
Next Earnings (Estimated)
9/11/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,959
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$1.50
High Stock Price Target
C$1.50
Low Stock Price Target
C$1.50
Potential Upside/Downside
+435.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
C$-40,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.05 per share
Book Value
C$0.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$84.95 million
Optionable
Not Optionable
Beta
1.53
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Philip M. Toleikis B.A.
    M.Sc., Ph.D., President, CTO, Director of Technology & Director
  • Mr. Christopher Barnes
    Vice President of Investor Relations
  • Dr. Frank Shannon M.D.
    Vice President of Clinical Development & Regulatory Affairs
  • Ms. Cynthia Pussinen
    CEO & Director
  • Mr. Nicholas J. Rossettos CPA (Age 58)
    M.B.A., Interim Chief Financial Officer
  • Mr. Douglas Maret
    Chief Science Officer
  • Dr. Modestus Obochi M.B.A.
    Ph.D., Chief Business Officer

SVA Stock Analysis - Frequently Asked Questions

How have SVA shares performed this year?

Sernova's stock was trading at C$0.70 at the beginning of 2024. Since then, SVA stock has decreased by 60.0% and is now trading at C$0.28.
View the best growth stocks for 2024 here
.

How were Sernova's earnings last quarter?

Sernova Corp. (TSE:SVA) released its earnings results on Friday, June, 14th. The company reported ($0.03) EPS for the quarter, hitting analysts' consensus estimates of ($0.03).

How do I buy shares of Sernova?

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:SVA) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners